Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3039744	s-rnapol3	— (—)	244	257	100.00%	Distribution not available
3039744	s-rnapoab	— (—)	105	109	100.00%	Distribution not available
3039744	s-rnapol3	U/ml (u/ml)	26	26	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Systemic connective tissue disorders

143

16.37

169.65

1.0

1.1

6.38

3.59

u/ml

—

Other systemic involvement of connective tissue

104

15.63

120.47

1.0

1.1

5.71

3.81

u/ml

—

ILD medications: immunosuppressive drugs

137

129

9.64

111.85

1.0

3.81

1.68

u/ml

—

ILD medications: prednisolone, methylprednisolone, prednisone

153

139

6.13

68.42

1.1

1.0

7.00

1.68

u/ml

1.67

ILD medications

157

142

5.97

67.54

1.1

1.0

7.20

1.68

u/ml

1.60

Reimbursement for rheumatic diseases

113

183

6.15

65.83

1.0

1.1

7.19

3.78

u/ml

—

Second line medication for Crohn's disease

111

191

5.82

61.25

1.0

1.1

4.21

5.28

u/ml

—

L04AX Other immunosuppressants

108

183

5.91

60.60

1.0

1.1

4.21

5.28

u/ml

—

Oral corticosteroids

153

183

4.91

56.94

1.0

1.1

5.88

1.45

u/ml

—

Inflammatory bowel disease treatment related agents

151

189

4.44

49.20

1.1

6.71

1.45

u/ml

—

ILD, hospital admissions 1, main diag only

14.09

45.89

1.0

1.1

5.50

1.80

u/ml

—

ILD, hospital admissions

12.30

44.40

1.0

1.1

5.50

1.80

u/ml

—

Interstitial lung disease endpoints

12.29

44.40

1.0

1.1

5.50

1.80

u/ml

—

Other interstitial pulmonary diseases

12.29

44.40

1.0

1.1

5.50

1.80

u/ml

—

Interstitial lung disease

12.29

44.40

1.0

1.1

5.50

1.80

u/ml

—

Other respiratory diseases principally affecting the interstitium

9.84

40.04

1.0

1.1

5.50

2.57

u/ml

—

First line medication for Crohn's disease

129

162

4.29

40.00

1.0

7.20

1.45

u/ml

—

Pain in joint

5.45

36.08

1.0

1.1

3.00

4.95

u/ml

—

Autoimmune diseases related-to ILD

104

237

3.67

31.11

1.0

1.1

5.93

3.64

u/ml

—

Diseases of arteries, arterioles and capillaries

151

4.23

30.16

1.1

1.0

6.40

5.41

u/ml

—

Autoimmune diseases excluding thyroid diseases

116

179

3.51

28.21

1.1

1.0

2.65

2.46

u/ml

—

Autoimmune diseases excluding thyroid diseases, strict definition

111

174

3.47

26.61

1.1

1.0

2.65

2.46

u/ml

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

29.73

25.73

1.0

5.50

—

u/ml

—

Abnormal findings on diagnostic imaging of lung

141

4.37

25.66

1.1

1.0

9.63

2.62

u/ml

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

195

3.62

24.16

1.1

1.0

9.78

2.32

u/ml

—

Abnormalities of breathing

170

3.27

21.78

1.0

7.95

3.17

u/ml

—

Autoimmune diseases

102

180

2.88

18.03

1.1

1.0

6.30

2.46

u/ml

—

Rheumatoid arthritis, including avohilmo

133

3.84

17.34

1.0

6.71

3.36

u/ml

—

Dyspnoea

258

2.66

16.30

1.0

1.1

9.75

2.60

u/ml

—

Gastro-oesophageal reflux disease

214

2.92

15.71

1.0

3.00

4.58

u/ml

—

All chronic kidney diseases

150

3.24

15.22

1.1

1.0

2.86

3.89

u/ml

—

Renal failure

125

3.48

14.44

1.1

1.0

6.50

5.75

u/ml

—

Used for control exclusion in common control thyroid runs

165

2.72

14.36

1.1

1.0

5.67

2.45

u/ml

—

Diseases of oesophagus, stomach and duodenum

101

243

2.45

14.07

1.1

1.0

5.63

4.21

u/ml

0.21

Implicit bacterial Sepsis, including avohilmo

121

3.44

13.85

1.1

1.0

9.06

3.14

u/ml

—

Bacterial infection, other or unspecified, including avohilmo

171

2.92

12.98

1.1

1.0

8.20

3.61

u/ml

—

Systemic lupus erythematosus

28.64

12.97

1.1

1.2

—

Bacterial infection, other or unspecified

147

3.10

12.79

1.1

1.0

8.20

3.61

u/ml

—

Bacterial Sepsis

127

3.26

12.75

1.1

1.0

8.45

3.14

u/ml

—

Implicit bacterial Sepsis

112

3.45

12.64

1.1

1.0

9.06

3.25

u/ml

—

SLE, ICD10

20.25

12.47

1.1

—

SLE, strict definition

20.25

12.47

1.1

—

Fever of other and unknown origin

160

2.98

12.28

1.0

2.30

2.56

u/ml

—

Other bacterial diseases, including avohilmo

250

2.35

12.17

1.1

1.0

7.50

2.88

u/ml

0.80

Other bacterial diseases

234

2.41

11.81

1.1

1.0

7.50

2.81

u/ml

0.82

Abdominal and pelvic pain

167

2.47

11.09

1.1

1.0

4.07

4.95

u/ml

—

Symptoms and signs involving the digestive system and abdomen

167

2.46

11.04

1.1

1.0

6.05

4.95

u/ml

0.13

Headache

180

2.66

11.02

1.1

1.0

6.57

2.64

u/ml

—

Other soft tissue disorders, not elsewhere classified

206

2.35

10.79

1.0

1.1

5.00

4.47

u/ml

—

Renal tubulo-interstitial diseases

256

2.32

10.69

1.1

1.0

8.67

2.71

u/ml

—

Hypothyroidism, strict autoimmune

149

2.69

10.58

1.0

12.25

2.50

u/ml

—

Pneumonia, organism unspecified

248

2.29

10.54

1.1

1.0

8.20

2.69

u/ml

—

GASTRO-related operations

116

2.73

10.31

1.1

3.69

3.08

u/ml

—

Any gastric operation

116

2.73

10.31

1.1

3.69

3.08

u/ml

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

272

2.21

10.28

1.1

1.0

6.73

2.81

u/ml

0.79

Systemic lupus erythematosus, unspecified

18.97

10.27

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

287

2.30

9.66

1.1

1.0

1.92

5.32

u/ml

—

Heart failure, not strict

166

2.51

9.53

1.0

10.38

2.61

u/ml

—

Symptoms and signs involving the circulatory and respiratory systems

171

2.32

9.43

1.0

6.57

3.17

u/ml

—

General symptoms and signs

187

2.25

9.42

1.1

1.0

9.44

2.64

u/ml

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

204

2.26

9.39

1.1

1.0

8.78

2.35

u/ml

—

204

2.26

9.39

1.1

1.0

8.78

2.35

u/ml

—

Diseases of the skin and subcutaneous tissue

176

2.28

9.26

1.0

4.21

5.31

u/ml

—

Influenza and pneumonia

267

2.10

9.21

1.1

1.0

8.89

2.69

u/ml

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

224

2.13

9.09

1.0

6.64

3.19

u/ml

0.54

Persons encountering health services in other circumstances, wide

224

2.11

8.97

1.1

1.0

7.40

3.19

u/ml

—

Implicit Sepsis, including avohilmo

224

2.26

8.91

1.1

1.0

8.94

2.53

u/ml

—

Implicit Sepsis

208

2.30

8.55

1.1

1.0

9.81

2.53

u/ml

—

Pain (limb, back, neck, head abdominally)

2.72

8.53

1.1

4.25

4.95

u/ml

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

273

2.07

8.49

1.1

1.0

8.20

2.69

u/ml

—

Pneumonias (Asthma/COPD co-morbidities)

273

2.06

8.38

1.1

1.0

8.20

2.69

u/ml

—

Localized scleroderma [morphea]

+∞

8.35

1.1

0.0

—

All pneumoniae

273

2.05

8.26

1.1

1.0

8.20

2.69

u/ml

—

All kidney diseases

275

2.05

8.14

1.1

1.0

7.90

2.81

u/ml

—

Condition for Implicit Sepsis (Organ dysfunction codes)

228

2.16

7.94

1.1

1.0

8.45

2.53

u/ml

—

Bacterial intestinal infections, IBD co-morbidities

3.78

7.78

1.0

7.00

3.81

u/ml

—

Abnormalities of heart beat

107

2.99

7.76

1.1

1.0

2.60

3.56

u/ml

—

Haemorrhage from respiratory passages

3.42

7.66

1.0

13.60

4.75

u/ml

—

Dermatitis and eczema

271

1.97

7.63

1.1

1.0

3.21

4.87

u/ml

—

Other bacterial intestinal infections

3.72

7.61

1.0

7.00

3.81

u/ml

—

Haemolytic-uraemic syndrome

+∞

7.38

1.0

0.0

—

Complications of procedures, not elsewhere classified

277

2.06

7.37

1.1

1.0

6.00

4.30

u/ml

—

Asthma, excluding more controls

112

2.43

7.16

1.0

1.1

5.00

1.93

u/ml

—

Episodal and paroxysmal disorders

224

1.97

7.16

1.0

7.63

2.50

u/ml

1.04

Other diseases of pleura

125

2.64

6.99

1.0

11.90

3.78

u/ml

—

Complications of surgical and medical care, not elsewhere classified

284

1.93

6.80

1.1

1.0

6.00

4.20

u/ml

—

Persons encountering health services for specific procedures and health care

270

1.90

6.76

1.0

1.1

6.69

3.80

u/ml

—

Cough

117

2.71

6.69

1.1

1.0

6.67

3.67

u/ml

—

Asthma

117

2.34

6.64

1.0

1.1

5.00

1.93

u/ml

—

Other bacterial intestinal infections, including avohilmo

3.09

6.30

1.0

7.00

3.56

u/ml

—

Malaise and fatigue

129

2.44

6.18

1.0

6.90

2.71

u/ml

—

Diseases of the ear and mastoid process

249

1.83

6.11

1.0

1.1

3.35

5.33

u/ml

—

Tramadol

185

2.05

6.07

1.0

5.06

5.42

u/ml

—

Gout, FINNGEN

3.22

5.91

1.1

1.0

5.44

3.60

u/ml

—

Certain disorders involving the immune mechanism

3.40

5.85

1.1

6.80

3.79

u/ml

—

Other heart diseases, wide

233

1.90

5.73

1.1

1.0

6.63

2.38

u/ml

—

COPD/asthma related infections

204

1.89

5.72

1.0

6.67

2.35

u/ml

—

COPD/asthma/ILD related infections

204

1.89

5.72

1.0

6.67

2.35

u/ml

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

249

1.90

5.64

1.1

1.0

7.86

2.60

u/ml

0.97

Gout, idiopatic and unspecified

3.14

5.45

1.1

5.44

2.86

u/ml

—

Oxycodone

109

2.51

5.38

1.1

1.0

7.00

7.22

u/ml

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

274

1.80

5.29

1.0

6.17

4.66

u/ml

—

Other disorders of ear

253

1.84

5.26

1.1

1.0

2.86

5.37

u/ml

—

Heart failure,strict

110

2.35

5.17

1.1

1.0

11.75

2.80

u/ml

—

Gout, unspecified

3.34

5.15

1.1

5.44

3.17

u/ml

—

Kidney transplant status

10.04

5.02

1.1

1.0

—

Septicaemia

116

2.44

4.99

1.0

13.00

3.61

u/ml

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

262

1.80

4.96

1.0

1.1

10.79

2.53

u/ml

—

Presence of cardiac and vascular implants and grafts

2.43

4.73

1.0

6.50

7.44

u/ml

—

Disorders of the thyroid gland

259

1.78

4.71

1.1

9.81

2.53

u/ml

—

Sleep disorders (combined)

244

1.73

4.71

1.0

7.89

3.24

u/ml

—

Excluding asthma or asthma-COPD overlap

119

2.06

4.68

1.0

1.1

2.90

2.94

u/ml

—

Other pulmonary diagnosis

119

2.06

4.68

1.0

1.1

2.90

2.94

u/ml

—

Hypothyroidism, other/unspecified

249

1.80

4.67

1.0

1.1

12.25

2.50

u/ml

—

Soft tissue disorders

206

1.79

4.63

1.0

1.1

5.85

4.47

u/ml

—

Heart failure, strict

129

2.16

4.63

1.1

1.0

9.56

3.70

u/ml

—

Psoriatic and enteropathic arthropathies

5.46

4.59

1.1

—

COPD differential diagnosis

120

2.05

4.59

1.0

1.1

4.08

1.93

u/ml

—

ILD differential diagnosis

120

2.05

4.59

1.0

1.1

4.08

1.93

u/ml

—

Explicit Sepsis

133

2.26

4.53

1.0

13.00

3.14

u/ml

—

Diagnoses used for exclusion with ILD

2.72

4.50

1.0

1.1

6.00

3.72

u/ml

—

Sleep apnoea

253

1.74

4.36

1.0

1.1

9.71

3.13

u/ml

—

Nerve, nerve root and plexus disorders

279

1.68

4.22

1.1

1.0

6.64

4.00

u/ml

—

Complications of medical and surgical care

285

1.80

4.21

1.1

1.0

6.60

4.25

u/ml

—

Explicit Sepsis, including avohilmo

137

2.18

4.20

1.0

13.00

3.14

u/ml

—

Disorders of vitreous body

178

2.03

4.07

1.1

1.0

1.71

7.07

u/ml

—

Other and unspecified anaemias

139

2.16

4.01

1.1

1.0

7.70

5.20

u/ml

—

Nutritional anaemias

180

2.01

3.98

1.1

1.0

8.35

2.88

u/ml

—

Other anaemias

139

2.16

3.98

1.1

1.0

7.70

5.20

u/ml

—

Other and unspecified iron deficiency

130

2.23

3.95

1.1

1.0

11.07

3.15

u/ml

—

Exposure to other specified factors

303

1.73

3.94

1.0

1.1

6.20

4.14

u/ml

—

All-cause Heart Failure

129

2.05

3.93

1.1

1.0

9.56

3.70

u/ml

—

Exposure to unspecified factor

304

1.65

3.93

1.0

1.1

2.20

4.94

u/ml

—

Aplastic and other anaemias

143

2.11

3.90

1.1

1.0

7.70

5.20

u/ml

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

255

1.71

3.90

1.0

1.1

12.25

2.58

u/ml

—

Hard cardiovascular diseases

197

1.77

3.85

1.1

1.0

5.75

4.89

u/ml

—

Disorders of vitreous body and globe

181

1.99

3.84

1.1

1.0

1.71

7.07

u/ml

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

285

1.66

3.84

1.1

1.0

2.09

6.08

u/ml

1.26

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

244

1.85

3.80

1.1

1.0

6.60

4.40

u/ml

—

Other arrhythmias

184

1.87

3.74

1.1

1.0

3.94

2.45

u/ml

—

Cardiac arrhythmias

166

1.85

3.71

1.1

1.0

6.36

3.56

u/ml

—

Neurological diseases

157

1.79

3.67

1.1

1.0

2.44

3.07

u/ml

—

Seropositive rheumatoid arthritis, wide

2.37

3.64

1.1

1.0

8.80

3.75

u/ml

—

Erysipelas, including avohilmo

190

1.83

3.62

1.0

7.42

3.15

u/ml

—

Iron deficiency anaemia

159

2.04

3.61

1.1

1.0

9.94

2.88

u/ml

—

Other disorders of lacrimal gland

150

2.07

3.55

1.1

1.0

—

4.76

—

Other and unspecified rosacea

3.88

3.48

1.2

1.1

—

3.40

—

Disorders of skin appendages

213

1.87

3.46

1.1

1.0

—

5.36

—

Rosacea

2.98

3.41

1.1

—

3.79

—

Certain infectious and parasitic diseases

191

1.68

3.40

1.0

7.50

2.58

u/ml

—

Acute tubulo-interstitial nephritis

199

1.82

3.37

1.0

7.90

2.80

u/ml

—

Sleep apnoea, including avohilmo

268

1.60

3.30

1.0

1.1

9.71

2.93

u/ml

—

Other disorders of eye and adnexa

2.92

3.29

1.1

—

3.79

—

Chronic tubulo-interstitial nephritis

8.60

3.26

1.2

1.0

—

Biological medication for rheuma

2.58

3.20

1.0

—

3.40

—

Diseases of the respiratory system

1.95

3.17

1.1

4.08

2.00

u/ml

—

Leiomyoma of uterus

170

1.72

3.10

1.0

1.1

6.17

3.88

u/ml

—

COPD

116

2.03

3.09

1.0

9.20

4.73

u/ml

—

Intestinal infectious diseases, including avohilmo, including avohilmo

282

1.54

3.05

1.0

5.50

4.21

u/ml

—

Opioids

204

1.62

3.04

1.1

1.0

2.64

5.42

u/ml

—

Other and unspecified disorders of vitreous body

163

1.92

3.03

1.0

1.50

7.07

u/ml

—

Psoriatic arthropathies

4.29

2.99

1.1

1.0

—

Other chronic obstructive pulmonary disease

113

2.03

2.99

1.0

9.20

4.73

u/ml

—

Torsion of ovary, ovarian pedicle and fallopian tube

10.04

2.98

1.0

1.2

—

Alopecia areata

10.04

2.98

1.0

1.2

—

Pneumonia due to other infectious organisms, not elsewhere classified

10.03

2.98

1.0

—

Migraine without aura

2.40

2.96

1.2

1.1

—

3.10

—

Dizziness and giddiness

250

1.65

2.93

1.1

1.0

1.75

6.21

u/ml

—

COPD, early/later onset

117

2.01

2.93

1.0

1.1

9.20

4.90

u/ml

—

Non-ischemic cardiomyopathy

2.17

2.90

1.1

1.0

8.30

2.33

u/ml

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

2.21

2.89

1.1

1.0

8.80

3.94

u/ml

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

6.69

2.87

1.0

1.1

—

Other chronic obstructive pulmonary disease, including avohilmo

150

1.86

2.87

1.0

7.92

4.66

u/ml

—

Varicella [chickenpox], including avohilmo

6.67

2.86

1.0

1.1

—

Benzodiazepine use

302

1.54

2.85

1.0

1.1

6.67

3.94

u/ml

—

Other/unspecified seropositive rheumatoid arthritis

2.19

2.82

1.1

1.0

8.80

3.94

u/ml

—

Open wound of lower leg

2.77

2.81

1.2

1.0

—

2.79

—

Disorders of lacrimal system

190

1.81

2.81

1.1

—

5.26

—

249

1.53

2.80

1.1

1.0

7.38

2.44

u/ml

—

Hypertensive diseases

194

1.63

2.79

1.0

4.25

5.14

u/ml

—

Intestinal infectious diseases

306

1.55

2.79

1.1

1.0

6.33

4.11

u/ml

—

Pericarditis

8.36

2.75

1.2

1.0

—

Right bundle-branch block

8.35

2.75

1.0

—

Lower back pain or/and sciatica

300

1.51

2.73

1.0

1.1

1.33

5.27

u/ml

—

Presence of other devices

2.25

2.73

1.0

2.60

7.44

u/ml

—

Reactive arthropathies, FINNGEN

5.01

2.72

1.1

—

Acute upper respiratory infections

270

1.53

2.72

1.0

11.29

2.38

u/ml

—

Covid-19 suspected case

2.28

2.67

1.1

—

3.50

—

Coagulation defects, purpura and other haemorrhagic conditions

2.46

2.61

1.0

—

3.72

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

4.67

2.59

1.0

1.1

—

Hypertension

194

1.60

2.58

1.0

4.25

5.14

u/ml

—

Purpura and other haemorrhagic conditions

3.06

2.56

1.0

1.1

—

4.90

—

Codeine or tramadol medication

274

1.49

2.55

1.0

2.58

5.66

u/ml

—

Polyarthritis, unspecified

7.16

2.55

1.0

1.1

—

Congenital deformities of feet, including avohilmo

7.16

2.55

1.2

1.1

—

Migraine without aura and triptan purchases

2.42

2.53

1.2

1.1

—

1.50

—

Nail disorders

3.47

2.48

1.0

1.1

—

3.40

—

Spondylopathies

179

1.62

2.45

1.0

1.1

7.67

3.23

u/ml

—

Metabolic disorders

253

1.52

2.45

1.1

1.0

7.30

4.18

u/ml

—

STROKE

140

1.73

2.37

1.1

1.0

1.57

5.29

u/ml

—

Varicella [chickenpox]

6.26

2.37

1.0

1.1

—

Crohn disease (strict definition, require KELA, min 2 HDR)

4.13

2.36

1.0

1.1

—

Other Crohn's disease

4.12

2.36

1.0

1.1

—

Deep endometriosis

3.04

2.35

1.0

1.1

—

4.75

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

287

1.47

2.27

1.1

1.0

2.60

4.21

u/ml

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

5.57

2.21

1.0

1.1

—

Bronchitis

294

1.45

2.21

1.1

1.0

8.43

3.25

u/ml

—

Cervicalgia

2.19

2.20

1.0

—

3.75

—

Erysipelas

160

1.72

2.19

1.1

1.0

8.70

3.65

u/ml

—

Hypertension, essential

190

1.55

2.18

1.0

7.92

5.14

u/ml

—

Fitting and adjustment of other devices

100

1.94

2.17

1.0

3.17

5.41

u/ml

—

Recurrent dislocation and subluxation of joint

4.29

2.15

1.0

1.1

—

Chronic lower respiratory diseases

285

1.42

2.14

1.1

1.0

6.67

3.55

u/ml

—

Unspecified mental disorder

167

0.36

2.12

1.0

—

5.21

—

Symptoms and signs involving the urinary system

229

1.55

2.10

1.1

1.0

3.81

5.56

u/ml

—

Benign neoplasm: Caecum

3.08

2.01

1.1

1.0

—

3.10

—

Kela-code for severe mental illness

147

0.34

1.99

1.0

—

5.54

—

Separation of retinal layers (serosa)

4.56

1.94

1.0

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

162

1.70

1.92

1.0

6.90

5.13

u/ml

—

Conductive and sensorineural hearing loss

211

1.51

1.91

1.0

3.20

5.61

u/ml

—

Bacterial pneumonia (organism specified)

142

1.72

1.89

1.0

7.00

5.07

u/ml

—

Stroke, including SAH

161

1.60

1.88

1.1

1.0

1.57

7.17

u/ml

—

Superficial injury of lower leg

100

1.90

1.85

1.0

—

5.64

—

Shoulder lesions

177

1.52

1.84

1.0

1.1

3.00

4.71

u/ml

—

Tobacco use

4.17

1.82

1.2

1.1

—

Alcohol-induced chronic pancreatitis

4.17

1.82

1.0

—

Other disorders of urethra and urinary system

230

1.48

1.81

1.1

7.14

4.00

u/ml

—

Vocal cord dysfunction

3.08

1.79

1.0

—

Cerebrovascular diseases

191

1.52

1.78

1.1

1.0

2.89

6.28

u/ml

—

Spinal stenosis

117

1.70

1.77

1.0

5.43

3.59

u/ml

—

Bleeding

228

1.48

1.75

1.1

1.0

8.06

3.18

u/ml

—

Other predominantly sexually transmitted diseases, not elsewhere classified

2.09

1.75

1.1

1.0

—

3.50

—

Syncope and collapse

115

1.74

1.75

1.1

1.0

4.33

2.86

u/ml

—

COPD related to multimorbidity

104

1.79

1.74

1.0

9.20

5.11

u/ml

—

Other psoriatic arthropathies

2.50

1.74

1.1

—

3.40

—

Ulcer of lower limb, not elsewhere classified

2.50

1.73

1.1

—

3.58

—

Seropositive rheumatoid arthritis, strict definition

2.22

1.73

1.0

1.1

8.80

3.25

u/ml

—

Acute lymphadenitis

3.85

1.71

1.2

1.0

—

Other diseases of upper respiratory tract

243

1.39

1.68

1.0

1.1

2.00

5.52

u/ml

—

Zoster [herpes zoster]

2.10

1.65

1.0

—

2.94

—

Peripheral artery operations in Hilmo

2.80

1.64

1.1

—

3.50

—

Exclusions for E4_PCOS_CONSORTIUM

216

1.44

1.63

1.0

1.1

7.50

3.39

u/ml

—

Sequelae of other external causes

3.58

1.61

1.2

1.1

—

Sensorineural hearing loss

188

1.49

1.61

1.0

3.20

5.61

u/ml

—

Other noninfective gastroenteritis and colitis

1.90

1.59

1.1

1.0

—

3.72

—

Spirochaetal infections, other/unspecified

2.70

1.58

1.1

—

3.10

—

Crohn disease

2.27

1.55

1.0

—

3.40

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

137

1.68

1.54

1.1

1.0

—

5.57

—

Tumor necrosis factor alpha inhibitors

2.03

1.54

1.0

—

3.40

—

Benign neoplasm of meninges

0.00

1.52

0.0

1.1

—

3.79

—

Infections of breast associated with childbirth

3.34

1.52

1.2

1.1

—

Congenital malformations of eye, ear, face and neck

3.34

1.52

1.0

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

242

1.37

1.51

1.1

1.0

1.70

5.70

u/ml

—

Other diseases of intestines

271

1.36

1.50

1.0

1.1

9.06

2.44

u/ml

—

Bacterial pneumoniae

114

1.69

1.50

1.0

7.00

3.60

u/ml

—

Constipation

263

1.39

1.48

1.0

7.58

3.91

u/ml

—

Other symptoms and signs involving cognitive functions and awareness

150

1.60

1.48

1.0

2.50

8.21

u/ml

—

Benign neoplasm of other and unspecified endocrine glands

2.22

1.46

1.0

1.1

—

3.79

—

Psoriatic arthropathies, ICD10

2.37

1.45

1.1

—

3.40

—

Acute upper respiratory infections of multiple and unspecified sites

242

1.42

1.45

1.1

1.0

10.80

2.44

u/ml

—

Keratitis

148

1.62

1.43

1.0

1.1

—

7.07

—

Other dorsopathies, not elsewhere classified

219

1.38

1.43

1.0

1.1

11.08

3.07

u/ml

—

Inflammatory disease of uterus

2.04

1.43

1.1

—

4.60

—

Retinal detachments and breaks

125

1.68

1.43

1.0

—

7.10

—

Infections with a predominantly sexual mode of transmission

133

1.65

1.40

1.1

—

3.82

—

Erosion of teeth , including avohilmo

103

1.75

1.40

1.1

—

3.22

—

Arthropathic psoriasis

2.25

1.40

1.2

1.1

—

3.40

—

Other embolism and thrombosis

2.25

1.40

1.0

1.1

—

4.06

—

Paracetamol or NSAID medication

2.69

1.38

1.1

1.0

—

Other sexually transmitted chlamydial diseases

2.61

1.36

1.2

1.0

—

Schizophrenia or delusion

124

0.40

1.35

1.0

—

6.18

—

Schizophrenia, schizotypal and delusional disorders

124

0.40

1.35

1.0

—

6.18

—

Stroke, excluding SAH

154

1.50

1.33

1.1

1.0

1.57

7.17

u/ml

—

Bacterial pneumonia, not elsewhere classified

105

1.67

1.32

1.1

1.0

7.00

3.83

u/ml

—

Nonsuppurative otitis media

1.81

1.28

1.0

1.1

—

3.28

—

Use of hypnotics and sedatives

277

1.32

1.27

1.0

1.1

2.67

5.61

u/ml

—

Retinal breaks without detachment

2.00

1.27

1.0

—

4.30

—

Benign neoplasm: Ascending colon

2.05

1.26

1.0

1.1

—

2.93

—

Noninfectious colitis NAS

2.05

1.26

1.0

1.1

—

3.69

—

Sleep disorders

288

1.34

1.26

1.1

1.0

6.60

4.20

u/ml

—

Dorsopathies

219

1.34

1.25

1.0

1.1

6.56

3.07

u/ml

—

Mycoses, including avohilmo

320

1.33

1.24

1.1

6.29

3.93

u/ml

—

Pregnancy, childbirth and the puerperium

0.45

1.23

1.0

—

2.06

—

Ulcerative colitis, NAS

2.04

1.22

1.0

—

3.40

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

278

1.32

1.18

1.0

1.1

8.08

3.81

u/ml

—

Injuries to the hip and thigh

169

1.49

1.17

1.1

1.0

1.90

7.10

u/ml

—

Ischaemic Stroke, excluding all haemorrhages

144

1.48

1.17

1.1

1.0

1.30

6.91

u/ml

—

Abnormal findings on diagnostic imaging of other body structures

2.00

1.16

1.1

1.0

—

3.00

—

Fracture of femur

1.73

1.15

1.1

1.90

5.55

u/ml

—

Benign neoplasm: Cerebral meninges

0.00

1.14

0.0

1.1

—

2.75

—

Other disorders of bone

1.85

1.13

1.1

1.0

—

3.79

—

Nonsuppurative otitis media, including avohilmo

102

1.61

1.12

1.0

1.1

—

3.35

—

Other congenital malformations, including avohilmo

2.00

1.12

1.0

1.1

—

3.40

—

Schizophrenia or delusion, excluding more controls

113

0.44

1.11

1.0

—

5.45

—

Other complications of surgical and medical care, not elsewhere classified

2.26

1.10

1.0

1.1

—

4.50

—

Viral hepatitis

2.38

1.09

1.2

1.0

—

Degenerative macular diseases

2.19

1.08

1.0

1.1

—

3.50

—

Hydronephrosis

2.19

1.08

1.0

—

3.50

—

Behavioural syndromes associated with physiological disturbances and physical factors

291

1.30

1.08

1.1

1.0

6.60

4.20

u/ml

—

Other inflammation of eyelid

1.92

1.06

1.1

—

3.92

—

Complications predominantly related to the puerperium

121

1.57

1.05

1.2

1.0

—

3.82

—

Asthma, including avohilmo

300

1.27

1.05

1.1

1.0

5.00

4.38

u/ml

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

1.71

1.05

1.1

1.0

—

2.93

—

Car occupant injured in other and unspecified transport accidents

1.79

1.04

1.1

—

4.25

—

Viral hepatitis, including avohilmo

2.27

1.03

1.2

1.0

—

Retinal vascular occlusion

2.06

1.02

1.0

1.1

—

3.50

—

Pollen allergy

1.73

1.02

1.1

—

3.25

—

Viral and other specified intestinal infections, including avohilmo

102

1.60

1.02

1.1

—

3.35

—

Retinal vascular disorders

2.00

1.00

1.0

1.1

—

3.50

—

Haemorrhoids and perianal venous thrombosis

130

1.53

0.99

1.0

1.1

2.20

3.25

u/ml

—

Malignant neoplasm of digestive organs

110

0.56

0.95

1.0

—

3.77

—

Chronic rhinitis, nasopharyngitis and pharyngitis

125

1.52

0.93

1.0

1.1

—

7.92

—

Other and unspecified vascular occlusions

2.22

0.93

1.0

1.1

—

3.50

—

Unspecified fall

196

1.40

0.93

1.0

1.1

7.50

4.76

u/ml

—

Chondropathies

1.82

0.92

1.1

—

3.79

—

Any death

169

1.37

0.90

1.1

1.0

11.42

3.57

u/ml

—

Medical treatment for female infertility

101

1.57

0.90

1.0

1.1

—

2.90

—

Acute laryngitis and tracheitis

1.92

0.89

1.0

—

Primary hyperparathyroidism

1.82

0.85

1.0

—

2.93

—

Other metabolic disorders

1.82

0.85

1.0

1.1

—

4.00

—

Diabetic nephropathy, excluding more controls

1.76

0.83

1.3

1.1

—

6.33

—

Myocardial infarction, without ST-elevation

116

1.48

0.83

1.1

—

5.75

—

Diabetic nephropathy

1.72

0.81

1.3

1.1

—

5.11

—

Superficial injury of ankle and foot

1.70

0.80

1.3

1.0

—

3.40

—

Impacted cerumen

1.82

0.79

1.0

1.1

—

3.21

—

Alzheimer’s disease (Atypical or mixed)

0.00

0.79

0.0

1.1

—

3.42

—

Malignant neoplasm of digestive organs, including Hilmo

120

0.61

0.77

1.0

—

3.77

—

Endocrine, nutritional and metabolic diseases

174

1.28

0.76

1.1

1.0

3.00

u/ml

—

Hypo-osmolality and hyponatraemia

1.69

0.75

1.1

1.0

—

6.00

—

Pregnancy with abortive outcome

162

1.29

0.74

1.1

1.0

8.40

3.33

u/ml

—

Chronic periodontitis, including avohilmo

291

1.23

0.73

1.1

1.0

1.92

5.41

u/ml

—

Long labour

105

1.45

0.73

1.1

1.0

—

3.10

—

L02BG Aromatase inhibitors

132

0.60

0.73

1.0

—

5.30

—

Periodontitis

291

1.23

0.73

1.1

1.0

1.92

5.41

u/ml

—

Corneal ulcer

1.67

0.72

1.1

1.0

—

4.25

—

Acne vulgaris

1.92

0.70

1.0

—

Selective serotonin reuptake inhibitors

233

1.23

0.70

1.1

1.0

6.22

4.00

u/ml

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1.71

0.70

1.0

1.1

—

4.00

—

Benign neoplasm: Rectum

1.55

0.69

1.1

1.0

—

3.50

—

Fall on same level

288

1.20

0.69

1.0

1.1

6.36

4.32

u/ml

—

Other intervertebral disc disorders

204

1.26

0.69

1.0

1.1

8.50

3.07

u/ml

—

Infections with a predominantly sexual mode of transmission, including avohilmo

162

1.35

0.69

1.1

—

3.82

—

Myocardial infarction, with ST-elevation

1.67

0.68

1.0

1.1

—

2.67

—

Combinations of oral blood glucose lowering drugs

0.54

0.66

1.0

—

7.94

—

Benign thyroid growths and nodules

111

1.42

0.65

1.1

1.0

—

2.63

—

Psoriasis vulgaris

1.61

0.65

1.1

1.0

—

3.79

—

Oral lichen planus, including avohilmo , including avohilmo

1.73

0.64

1.0

1.1

—

3.10

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

1.73

0.64

1.0

1.1

—

1.60

—

Nontoxic multinodular goitre

1.59

0.61

1.0

—

2.80

—

Disorders of gallbladder, biliary tract and pancreas

285

1.20

0.61

1.0

1.1

8.20

3.89

u/ml

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.58

0.60

1.0

—

3.40

—

Entropion and trichiasis of eyelid

0.00

0.60

0.0

1.0

—

3.10

—

D07AA Corticosteroids, weak (group I)

1.54

0.59

1.0

—

3.40

—

Thyrotoxicosis, other and/or unspecified

1.53

0.59

1.2

1.0

—

2.94

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

1.52

0.59

1.0

1.1

—

4.25

—

Vascular dementia

0.00

0.58

0.0

1.0

—

2.40

—

Hernia

276

1.20

0.58

1.1

1.0

3.42

5.30

u/ml

—

Colorectal cancer

0.58

0.56

1.0

—

3.95

—

Chronic sinusitis

176

1.31

0.55

1.0

1.1

—

7.00

—

DVT of lower extremities

1.45

0.53

1.0

—

3.72

—

Falls/tendency to fall

248

1.17

0.50

1.1

3.17

4.63

u/ml

—

Necrosis of pulp, including avohilmo

266

1.23

0.50

1.0

1.1

2.00

6.14

u/ml

—

Antepartum haemorrhage, not elsewhere classified

1.46

0.50

1.0

1.1

—

2.90

—

Psychiatric diseases

216

1.18

0.49

1.0

7.17

4.65

u/ml

—

Biguanides

282

0.83

0.49

1.1

1.0

2.67

5.45

u/ml

—

Thyrotoxicosis

102

1.37

0.47

1.1

1.0

—

6.08

—

Gingivitis and periodontal diseases

229

1.17

0.47

1.1

1.0

2.10

5.89

u/ml

—

Benign neoplasms

227

1.17

0.46

1.0

1.1

2.50

4.03

u/ml

—

Other strabismus

0.61

0.45

1.0

—

3.50

—

Hypertrophy of breast

0.61

0.45

1.0

—

4.33

—

Pedal cyclist injured in transport accident

0.60

0.45

1.2

1.0

—

3.79

—

Non-small cell lung cancer, including Hilmo

1.40

0.45

1.1

1.0

—

2.58

—

Rash and other nonspecific skin eruption

1.61

0.43

1.4

1.1

—

4.90

—

Other mental disorders due to brain damage and dysfunction and to physical disease

1.61

0.43

1.2

1.0

—

3.90

—

Exclusions for E4_PCOS_BROAD

1.43

0.42

1.1

—

4.25

—

Colorectal cancer, including Hilmo

0.63

0.42

1.0

—

3.95

—

Presbycusis

1.54

0.42

1.2

1.1

—

2.70

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

0.00

0.41

0.0

1.0

—

Other inflammation of vagina/vulva

0.00

0.41

0.0

1.1

—

Brain meningioma

0.00

0.41

0.0

1.1

—

2.90

—

Brain meningioma, including Hilmo

0.00

0.41

0.0

1.1

—

2.90

—

Benign neoplasm of mouth and pharynx

1.43

0.39

1.2

1.1

—

2.75

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1.43

0.39

1.0

—

8.20

—

Artrosis, including avohilmo

192

1.17

0.38

1.0

1.1

1.40

5.37

u/ml

—

Other disorders of amniotic fluid and membranes

1.36

0.38

1.1

1.0

—

2.90

—

Disorders of continuity of bone

1.39

0.38

1.0

1.1

—

4.25

—

Ptosis of eyelid

1.39

0.38

1.0

1.1

—

2.70

—

Benign neoplasm: Rectum, anus and anal canal

1.32

0.37

1.1

1.0

—

3.75

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

1.35

0.37

1.0

1.1

—

4.70

—

Injuries to the head

315

1.13

0.37

1.0

1.1

2.57

5.07

u/ml

—

Nontoxic goitre/thyroid nodule

116

1.29

0.37

1.1

1.0

—

5.54

—

Transport accidents

149

1.23

0.36

1.1

—

3.64

—

Endometriosis ASRM stages 1,2

1.36

0.36

1.1

—

4.75

—

Unspecified lump in breast

1.27

0.36

1.0

—

6.64

—

Other and unspecified nonorganic psychotic disorders

0.66

0.35

1.0

—

3.40

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

247

1.15

0.35

1.0

7.92

4.33

u/ml

—

Triptan medication for migraine, single purchase ok

247

1.15

0.35

1.0

7.92

4.33

u/ml

—

Urinary track infection

154

1.17

0.35

1.1

4.00

2.19

u/ml

—

Striking against or struck by other objects

126

1.27

0.34

1.1

1.0

—

5.09

—

Procreative management

111

1.26

0.34

1.1

—

3.50

—

FESS (DNB20)

1.36

0.34

1.0

—

3.40

—

Other inflammation of eyelid, including avohilmo

209

1.20

0.33

1.1

1.0

—

5.94

—

Malignant neoplasm

231

1.14

0.33

1.0

7.00

3.30

u/ml

—

Viral and other specified intestinal infections

1.36

0.32

1.0

1.1

—

3.56

—

Ethmoidectomy

1.28

0.32

1.0

—

3.40

—

Injuries to the elbow and forearm

276

1.15

0.31

1.0

1.1

9.00

3.88

u/ml

—

Malignant neoplasm

232

1.14

0.31

1.0

7.00

3.22

u/ml

—

Recurrent aphthous stomatitis , including avohilmo

1.35

0.31

1.1

—

3.81

—

Premature rupture of membranes

1.28

0.31

1.3

1.0

—

2.90

—

False labour

0.78

0.29

1.0

—

2.90

—

Dislocation, sprain and strain of joints and ligaments at neck level

1.25

0.29

1.1

1.0

—

3.40

—

Herpesviral [herpes simplex] infections, including avohilmo

103

1.26

0.28

1.1

—

3.18

—

Contact with and exposure to communicable diseases

128

0.78

0.27

1.0

1.1

—

2.50

—

Type 2 diabetes, definitions combined, including avohilmo

271

1.11

0.26

1.0

5.57

4.58

u/ml

—

Use of pramipexole

1.30

0.26

1.0

—

6.15

—

Bipolar affective disorders

1.17

0.24

1.0

—

2.79

—

Sequelae of injuries, of poisoning and of other consequences of external causes

1.28

0.24

1.0

—

6.44

—

Type 2 diabetes

279

1.10

0.24

1.0

1.1

6.33

4.39

u/ml

—

Paralytic ileus and intestinal obstruction

0.71

0.24

1.0

1.1

—

3.44

—

Seborrhoeic keratosis

0.71

0.24

1.2

1.0

—

5.18

—

Wide developmental disorders, excluding more controls

0.00

0.21

0.0

1.0

—

Specific development disorders of scholastic skills

0.00

0.21

0.0

1.1

—

Algoneurodystrophy

0.00

0.21

0.0

1.1

—

Bulimia nervosa (incl. atypical)

0.00

0.21

0.0

1.0

—

Disorders of orbit

0.00

0.21

0.0

1.1

—

0.00

0.21

0.0

1.1

—

Emotional disorders starting during childhood or adolescence

0.00

0.21

0.0

1.1

—

Preterm labour and delivery

122

0.82

0.19

1.1

1.0

—

3.05

—

Pain in thoracic spine

1.13

0.18

1.0

1.1

—

4.10

—

Voice disturbances

100

1.20

0.18

1.0

—

7.00

—

Injuries to the shoulder and upper arm

290

1.09

0.18

1.0

3.60

4.66

u/ml

—

Puerperal sepsis

1.17

0.17

1.0

1.1

—

5.21

—

Other disorders of breast

1.15

0.17

1.0

1.1

—

5.06

—

Other diseases of urinary system

260

1.08

0.17

1.0

3.72

3.88

u/ml

—

Benign neoplasm of other and ill-defined parts of digestive system

1.11

0.17

1.0

—

3.81

—

Colorectal adenocarcinoma

0.74

0.17

1.0

—

3.28

—

Type 2 diabetes, strict (exclude DM1)

270

1.08

0.16

1.0

6.33

4.39

u/ml

—

Type 2 diabetes, definitions combined

270

1.08

0.16

1.0

6.33

4.39

u/ml

—

Postpartum hemorraghe, parous women as controls

100

1.17

0.16

1.1

—

4.50

—

Stomatitis and related lesions

1.14

0.16

1.1

—

3.81

—

Maternal care for known or suspected malpresentation of fetus

1.19

0.16

1.1

1.0

—

2.90

—

Skin changes due to chronic exposure to nonionizing radiation

126

1.15

0.15

1.1

1.0

—

4.91

—

Type 1 diabetes, wide definition

0.78

0.15

1.3

1.1

—

8.25

—

Maternal care for known or suspected fetal abnormality and damage

1.14

0.15

1.2

1.0

—

2.90

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

0.81

0.14

1.0

—

3.77

—

Hypertrophy of breast in women and men

0.81

0.14

1.0

—

4.00

—

Type 1 diabetes

0.79

0.14

1.3

1.1

—

7.29

—

Varicose veins

192

0.90

0.14

1.0

9.50

4.12

u/ml

—

Strabismus

0.81

0.13

1.1

1.0

—

4.30

—

Postpartum hemorraghe, all women as controls

119

1.15

0.13

1.1

—

2.75

—

Sub-endpoint used in defining T1D endpoints

0.80

0.13

1.3

1.0

—

5.86

—

GI-bleeding

109

0.83

0.13

1.0

1.1

—

6.22

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

112

1.15

0.12

1.1

—

2.50

—

Diabetes, varying definitions

290

1.06

0.12

1.1

1.0

6.33

4.39

u/ml

—

Dementia, including avohilmo

115

0.89

0.12

1.0

1.1

2.40

5.55

u/ml

—

Intestinal stricture

116

0.86

0.12

1.0

—

7.10

—

Intracranial injury

232

1.08

0.11

1.0

2.80

5.89

u/ml

—

Persons with potential health hazards related to communicable diseases

156

0.89

0.11

1.0

1.1

—

3.58

—

Unstable angina pectoris

0.86

0.11

1.0

—

5.15

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

263

1.06

0.11

1.1

1.0

3.00

4.39

u/ml

—

Diabetes mellitus

290

1.05

0.11

1.1

1.0

6.33

4.39

u/ml

—

Diabetes medication

302

0.95

0.11

1.1

1.0

1.83

5.45

u/ml

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.16

0.11

1.2

1.0

—

4.18

—

Solid cancers

226

1.06

0.11

1.0

7.00

3.30

u/ml

—

Actinic keratosis

122

1.12

0.10

1.1

1.0

—

4.91

—

Other (not insulin) diabetes medications

283

0.95

0.08

1.0

2.43

5.45

u/ml

—

Panic disorder

0.83

0.08

1.0

1.1

—

1.70

—

Obstructed labour due to maternal pelvic abnormality

0.84

0.07

1.0

—

3.63

—

Type 1 diabetes, wide definition, subgroup 1

0.81

0.07

1.3

1.1

—

8.25

—

Substance use, excluding alcohol

1.05

0.07

1.0

—

7.00

—

Postpartum haemorrhage

105

1.10

0.07

1.1

1.0

—

3.10

—

Poisoning by medicine

0.85

0.07

1.0

—

3.00

—

Maternal care for known or suspected abnormality of pelvic organs

0.91

0.06

1.2

1.0

—

2.75

—

Cystitis

241

1.04

0.05

1.0

3.40

4.00

u/ml

—

Conjunctivitis (acute, non atopic)

110

1.09

0.04

1.0

—

3.41

—

Other diseases of the digestive system

109

0.92

0.04

1.0

1.1

—

6.22

—

Other antidepressants

233

1.03

0.04

1.1

1.0

8.60

4.00

u/ml

—

Diseases of pulp and periapical tissues and dental caries

135

1.03

0.00

1.1

1.0

2.00

7.08

u/ml

—

Insulin, fast-acting

135

0.96

0.00

1.2

1.1

—

6.87

—

Other spirochaetal diseases

138

1.01

0.00

1.1

1.0

—

7.13

—

Obstructed labour due to malposition and malpresentation of fetus

106

0.96

0.00

1.1

1.0

—

2.75

—

Insulin, fast-acting or short human

134

0.97

0.00

1.2

1.1

—

6.81

—

Spirochaetal infections, other/unspecified, including avohilmo

138

1.01

0.00

1.1

1.0

—

7.13

—

Glucagon-like peptide-1 (GLP-1) analogues

116

1.03

0.00

1.0

—

8.45

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

116

1.03

0.00

1.0

—

8.45

—

Other spirochaetal diseases, including avohilmo

141

0.99

0.00

1.1

1.0

—

7.13

—

Diabetes, insulin treatment (Kela reimbursement)

278

1.01

0.00

1.1

1.0

3.00

5.07

u/ml

—

Dental operations

134

1.00

0.00

1.1

1.0

4.42

7.32

u/ml

—

Lyme disease

137

1.02

0.00

1.1

1.0

—

7.13

—

Lyme disease, including avohilmo

137

1.02

0.00

1.1

1.0

—

7.13

—

Other disorders of iris and ciliary body

0.00

0.0

1.2

—

Schizotypal disorder

0.00

0.0

1.2

—

Wide developmental disorders

0.00

0.0

1.2

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

0.00

0.0

1.2

—

Iridocyclitis in diseases classified elsewhere

0.00

0.0

1.2

—

Superficial injury of head

1.00

0.00

1.0

—

6.28

—

Total colectomy

0.00

0.0

1.1

—

Use of cabergoline

0.00

0.0

1.2

—

Other disorders of binocular movement

0.00

0.0

1.1

—

Cerebral palsy

0.00

0.0

1.2

—

Personal history of certain other diseases

0.00

0.0

1.0

—

Malignant neoplasm of respiratory system and intrathoracic organs

0.98

0.00

1.1

1.0

—

2.58

—

Open wound of hip and thigh

0.00

0.0

1.2

—

Viral agents as the cause of diseases classified to other chapters, including avohilmo

0.00

0.0

1.2

—

Certain zoonotic bacterial diseases, including avohilmo

0.00

0.0

1.2

—

Paranoid personality disorder

0.00

0.0

1.2

—

Burns and corrosions confined to eye and internal organs

0.00

0.0

1.2

—

Disorders of globe

0.00

0.0

1.0

—

Total colectomy operation

0.00

0.0

1.1

—

Major anomalies of jaw size

0.00

0.0

1.2

—

Bacterial meningitis

0.00

-0.00

0.0

1.1

—

Lesion of radial nerve

0.00

-0.00

0.0

1.0

—

Melanocytic naevi of upper limb, including shoulder

0.00

-0.00

0.0

1.1

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

0.00

-0.00

0.0

1.1

—

Other salmonella infections

0.00

-0.00

0.0

1.0

—

Other and unspecified diseases of blood and blood-forming organs

0.00

-0.00

0.0

1.0

—

Gonococcal infection, including avohilmo

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Brain, supratentorial

0.00

-0.00

0.0

1.2

—

Effects of foreign body entering through natural orifice

0.98

-0.00

1.0

—

6.44

—

Benign neoplasm: Anus and anal canal

0.00

-0.00

0.0

1.2

—

Superficial injuries involving multiple body regions

0.00

-0.00

0.0

1.1

—

Chronic conjunctivitis

0.00

-0.00

0.0

1.1

—

Syphilis, including avohilmo

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of bronchus and lung, including Hilmo

1.01

-0.00

1.1

1.0

—

2.58

—

Unspecified maternal hypertension

0.00

-0.00

0.0

1.2

—

Syphilis

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of bronchus and lung

0.91

-0.00

1.2

1.0

—

2.58

—

Malignant neoplasm of brain

0.00

-0.00

0.0

1.0

—

Other facial nerve disorders

0.00

-0.00

0.0

1.1

—

Anaemia in chronic diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Other salmonella infections, including avohilmo

0.00

-0.00

0.0

1.0

—

Symptoms and signs involving emotional state

0.00

-0.00

0.0

1.2

—

Failed attempted abortion

0.00

-0.00

0.0

1.2

—

Hodgkin lymphoma, hilmo

0.00

-0.00

0.0

1.1

—

Exclusion endpoint for clefts

0.00

-0.00

0.0

1.1

—

Prolapse and hernia of ovary and fallopian tube

0.00

-0.00

0.0

1.0

—

Spinal instabilities

0.00

-0.00

0.0

1.0

—

Other mycoses, not elsewhere classified/unspecified, including avohilmo

0.00

-0.00

0.0

1.2

—

Acute nephritic syndrome

0.00

-0.00

0.0

1.0

—

Burn and corrosion confined to eye and adnexa

0.00

-0.00

0.0

1.2

—

Erythema intertrigo

0.00

-0.00

0.0

1.2

—

Burn and corrosion of head and neck

0.00

-0.00

0.0

1.2

—

Somnolence, stupor and coma

0.00

-0.00

0.0

1.1

—

Toxic effect of alcohol

0.00

-0.00

0.0

1.2

—

Superficial injury of neck

0.00

-0.00

0.0

1.2

—

Foreign body in ear

0.00

-0.00

0.0

1.2

—

Parapsoriasis

0.00

-0.00

0.0

1.2

—

Biological medicines for asthma

0.00

-0.00

0.0

1.2

—

Effects of other external causes

0.00

-0.00

0.0

1.1

—

Other and unspecified intracranial injuries

0.00

-0.00

0.0

1.1

—

Injury of muscle and tendon at forearm level

0.00

-0.00

0.0

1.2

—

Guttate psoriasis

0.00

-0.00

0.0

1.2

—

LSIL lesion of the cervix uteri, vagina or vulva

1.02

-0.00

1.0

1.1

—

3.50

—

Other and specified injuries of hip and thigh

0.00

-0.00

0.0

1.2

—

Aggressive periodontitis

0.00

-0.00

0.0

1.0

—

Scissor bite

0.00

-0.00

0.0

1.2

—

Thyrotoxicosis with diffuse goitre

1.00

-0.00

1.2

1.0

—

3.06

—

Injury of nerves at wrist and hand level

0.00

-0.00

0.0

1.1

—

Other or unspecified ileus, impaction or obstruction

1.02

-0.00

1.0

1.1

—

2.57

—

Hypertrophy of tongue papillae

0.00

-0.00

0.0

1.2

—

Intussusception

0.00

-0.00

0.0

1.2

—

Graves ophthalmopathy

0.00

-0.00

0.0

1.0

—

Distal bite

0.00

-0.00

0.0

1.1

—

Keratoconus

0.00

-0.00

0.0

1.2

—

Corneal degeneration

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Long bones of lower limb

0.00

-0.00

0.0

1.1

—

Open wound of shoulder and upper arm

0.00

-0.00

0.0

1.2

—

Assault by unspecified means

0.00

-0.00

0.0

1.2

—

Blood alcohol or alcohol intoxication level

0.00

-0.00

0.0

1.2

—

Oral leukoplakia, including avohilmo

0.00

-0.00

0.0

1.0

—

Evidence of alcohol involvement determined by blood alcohol level

0.00

-0.00

0.0

1.2

—

Accidental poisoning by and exposure to alcohol

0.00

-0.00

0.0

1.2

—

Autism spe, excluding more controls

0.00

-0.00

0.0

1.0

—

Other and unspecified epidermal thickening

0.00

-0.00

0.0

1.2

—

Suppurative otitis media, unspecified

0.00

-0.00

0.0

1.2

—

Intentional self-harm by sharp object

0.00

-0.00

0.0

1.2

—

Hyphaema and other vascular disorders of iris and ciliary body

0.00

-0.00

0.0

1.2

—

Chorioretinal inflammation

0.00

-0.00

0.0

1.0

—

Amblyopia ex anopsia

0.00

-0.00

0.0

1.1

—

Convergence insufficiency and excess

0.00

-0.00

0.0

1.2

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

0.00

-0.00

0.0

1.2

—

Exposure to other specified electric current

0.00

-0.00

0.0

1.2

—

Motorcycle rider injured in noncollision transport accidents

0.00

-0.00

0.0

1.2

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1.00

-0.00

1.1

1.0

—

2.50

—

Carrier of infectious disease

0.00

-0.00

0.0

1.1

—

0.00

-0.00

0.0

1.0

—

Deep bite that required surgery

0.00

-0.00

0.0

1.2

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

0.91

-0.00

1.0

1.1

—

3.79

—

Mental and behavioural disorders due to cannabinoids

0.00

-0.00

0.0

1.1

—

Donors of organs and tissues

0.00

-0.00

0.0

1.2

—

0.00

-0.00

0.0

1.2

—

Hypogonadotropic hypogonadism

0.00

-0.00

0.0

1.2

—

Graves ophthalmopathy, strict

0.00

-0.00

0.0

1.0

—

Endocrine disorders, other/unspecified

0.00

-0.00

0.0

1.1

—

Drug-induced adrenocortical insufficiency

0.00

-0.00

0.0

1.2

—

Viral agents as the cause of diseases classified to other chapters

0.00

-0.00

0.0

1.0

—

Background retinopathy and retinal vascular changes

0.00

-0.00

0.0

1.0

—

Other protozoal intestinal diseases, including avohilmo

0.00

-0.00

0.0

1.0

—

Postprocedural disorders of digestive system, not elsewhere classified

0.00

-0.00

0.0

1.1

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Habitual aborter

0.00

-0.00

0.0

1.2

—

Sixth [abducent] nerve palsy

0.00

-0.00

0.0

1.2

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

0.00

-0.00

0.0

1.1

—

Injury of muscle and tendon at ankle and foot level

0.00

-0.00

0.0

1.1

—

Other congenital malformations of circulatory system

0.00

-0.00

0.0

1.1

—

Gonococcal infection

0.00

-0.00

0.0

1.2

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

RNA polymerase III Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS